ConductScience.org, home

Paper528789

Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.

Kasper DL and 3 others. J Infect Dis, 1979. Cited by 50 papers, by iCite.

Cite this record

ConductScience Library. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis. Papers, record 528789. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/528789

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.
PubMed
Journal
J Infect Dis
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
1.53
iCite
Revised in PubMed
2019-05-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kasper DLD L
2Onderdonk ABA B
3Crabb JJ
4Bartlett JGJ G

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, BacterialMajor topic
Bacteroides InfectionsMajor topic
ImmunizationMajor topic
Abscess
Animals
Antibodies, Bacterial
Bacteroides fragilis
Cattle
Cell Membrane
Freund's Adjuvant
Male
Polysaccharides, Bacterial
Precipitins
Rats
Serum Albumin, Bovine

Source PubMed

Download CSV of topics

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
27377457Bioactivities, isolation and purification methods of polysaccharides from natural products: A review.Int J Biol Macromol2016https://conductscience.org/library/papers/27377457PubMed
27213458Entirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune Responses.Vaccines (Basel)2016https://conductscience.org/library/papers/27213458PubMed
27089515Activation of Bacteroides fragilis toxin by a novel bacterial protease contributes to anaerobic sepsis in mice.Nat Med2016https://conductscience.org/library/papers/27089515PubMed
25105360Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis.J Clin Invest2014https://conductscience.org/library/papers/25105360PubMed
22168411The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA.Immunol Rev2012https://conductscience.org/library/papers/22168411PubMed
11023954Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function.Clin Microbiol Rev2000https://conductscience.org/library/papers/11023954PubMed
8675640Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.J Clin Invest1995https://conductscience.org/library/papers/8675640PubMed
8349763Bacteroides fragilis strains express multiple capsular polysaccharides.J Clin Microbiol1993https://conductscience.org/library/papers/8349763PubMed
8039936Structure-function relationships for polysaccharide-induced intra-abdominal abscesses.Infect Immun1994https://conductscience.org/library/papers/8039936PubMed
7927768Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation.Infect Immun1994https://conductscience.org/library/papers/7927768PubMed
7106931Anaerobic bacterial infections in children-Part II.Indian J Pediatr1982https://conductscience.org/library/papers/7106931PubMed
6976357Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.J Clin Invest1982https://conductscience.org/library/papers/6976357PubMed
6185469Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: chemical and immunochemical characterization.J Bacteriol1983https://conductscience.org/library/papers/6185469PubMed
6174672Cellular immunity to Bacteroides fragilis capsular polysaccharide.J Exp Med1982https://conductscience.org/library/papers/6174672PubMed
3699894Inhibition of macrophage phagocytosis by Bacteroides fragilis in vivo and in vitro.Infect Immun1986https://conductscience.org/library/papers/3699894PubMed
3537321Tubo-ovarian abscess: pathogenesis and management.J Natl Med Assoc1986https://conductscience.org/library/papers/3537321PubMed
3516885T-lymphocyte involvement in abscess formation in nonimmune mice.Infect Immun1986https://conductscience.org/library/papers/3516885PubMed
2777372Intraperitoneal host cellular responses and in vivo killing of Bacteroides fragilis in a bacterial containment chamber.Infect Immun1989https://conductscience.org/library/papers/2777372PubMed
2671021Staphylococcus aureus exopolysaccharide in vivo demonstrated by immunomagnetic separation and electron microscopy.J Clin Microbiol1989https://conductscience.org/library/papers/2671021PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/528789

GET https://conductscience.org/api/papers/v1/528789/authors